Pune, India -- (SBWIRE) -- 01/29/2018 -- Global Infertility Testing Market is expected to reach 22,421.79 million by 2024 from 13,347.10 million in 2016, at a CAGR of 6.8% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The major factors driving the growth of Global Infertility Testing Market are significant decline in fertility rates, increasing number of fertility clinics, rising public awareness among the female population, increasing number of gynaecological disorders and technological advancements and innovative testing products. On the other hand, high cost of ovulation testing and accuracy issues with testing kits may hinder the growth of the market.

Request a Free Sample Copy: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-infertility-testing-market

Table of Content:


- Introduction

- Market Segmentation

- Market Overview

- Executive Summary

- Premium Insights

- Global Infertility Testing Market, By Industry

- Global Infertility Testing Market, Application

- Global Infertility Testing Market, By Region

- Global Infertility Testing Market, Company Landscape

- Company Profile

- Related Reports


Access Full TOC: http://databridgemarketresearch.com/toc/?dbmr=global-infertility-testing-market

Market Segmentation: 

The global infertility testing market is segmented on the basis of type, test kits, prescription mode, distribution channel and end user.

On the basis of test kits are further sub divided into human Follicular Stimulating Hormone (FSH) urine test kits, luteinizing hormone (LH) urine test kits, human chorionic gonadotropin (HCG) hormone blood test kits and others.

On the basis of prescription mode, the global infertility testing market is segmented into prescription-based and over the counter (OTC) based.

On the basis of end user, the global infertility testing market is classified into fertility centers, hospitals and clinics, research institutes and cryobanks.

For More Information: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-infertility-testing-market

Key Drivers:

The major factors driving the growth of this market are significant decline in fertility rates, increasing number of fertility clinics, rising public awareness among the female population, increasing number of gynaecological disorders and technological advancements and innovative testing products. On the other hand, high cost of ovulation testing and accuracy issues with testing kits may hinder the growth of the market.

Key Points:

The Merck KGaA is going to dominate the global infertility market followed by Procter & Gamble, bioMérieux SA and other players operating in this market are include Babystart Ltd, Biozhena Corporation, Quidel Corporation, Alere Inc., SPD Swiss Precision Diagnostics GmBH, Proctor & Gamble, SCSA Diagnostics, Inc., among others.

Access Full Report: http://databridgemarketresearch.com/reports/global-infertility-testing-market/

About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor: investors@databridgemarketresearch.com

Visit Blog: http://databridgemarketresearch.com/blog/

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research